Obesity and Insulin Resistance Are the Main Determinants of Postprandial Lipoprotein Dysmetabolism in Polycystic Ovary Syndrome

Table 4

Baseline characteristics adjusted for BMI, HOMA_IR, and log .

	Covariate: BMI		Covariate: HOMAIR		Covariate:
	PCOS	Controls	PCOS	Controls	PCOS	Controls
Systolic BP (mmHg)	124.6 ± 2.2	123.3 ± 2.2	124.4 ± 2.2	123.5 ± 2.2	125.0 ± 2.4	123.0 ± 2.6
Diastolic BP (mmHg)	78.0 ± 1.9	78.9 ± 1.9	78.6 ± 2.0	78.2 ± 2.0	78.6 ± 2.1	78.9 ± 2.3
Waist (cm)	107.3 ± 1.5	104.5 ± 1.5	109.0 ± 2.2	102.8 ± 2.2	108.8 ± 2.4	104.3 ± 2.6
Hip (cm)	116.6 ± 1.1	114.8 ± 1.1	118.7 ± 1.9	112.6 ± 1.9	118.4 ± 2.0	113.3 ± 2.2
Waist : Hip	0.920 ± 0.015	0.910 ± 0.015	0.917 ± 0.015	0.913 ± 0.015	0.919 ± 0.016	0.921 ± 0.017
Weight (kg)	89.2 ± 1.4	89.5 ± 1.4	91.2 ± 2.5	87.4 ± 2.5	91.0 ± 2.8	88.9 ± 3.0
BMI (kg/m^2)	—		35.3 ± 1.0	32.9 ± 0.9	35.4 ± 1.1	33.7 ± 1.2
% Body fat mass (%)	37.6 ± 1.2	36.2 ± 1.2	38.2 ± 1.7	35.7 ± 1.7	38.5 ± 1.8	36.2 ± 1.9
T (nmol/L)	3.37 ± 0.25	1.52 ± 0.24	3.24 ± 0.25	1.56 ± 0.25	3.49 ± 0.27	1.30 ± 0.279
SHBG (nmol/L)	32.2 ± 3.04	45.2 ± 2.98	31.4 ± 2.98	45.7 ± 2.98	34.2 ± 3.19	43.4 ± 3.45
FAI	12.2 ± 1.25	4.08 ± 1.22	12.2 ± 1.24	3.70 ± 1.24	12.5 ± 1.38	3.30 ± 1.50
Androstenedione (nmol/L)	15.67 ± 0.9	11.99 ± 0.89	15.07 ± 0.92	12.30 ± 0.90	15.98 ± 0.99	11.37 ± 1.05
DHEAS (μmol/L)	8.00 ± 0.68	4.80 ± 0.66	7.88 ± 0.66	4.72 ± 0.66	8.55 ± 0.66	3.80 ± 0.72
HOMAIR (μmol^2/L^2)	3.99 ± 0.35	3.02 ± 0.34	—		3.91 ± 0.38	3.39 ± 0.41
(×10^−4 min^−1/mU/L)	2.23 ± 0.31	3.78 ± 0.34	2.33 ± 0.30	3.66 ± 0.32	—
(min^−1)	0.02 ± 0.00	0.02 ± 0.00	0.02 ± 0.00	0.02 ± 0.00	0.02 ± 0.00	0.02 ± 0.00
AIRG (mU⋅L^−1⋅min)	986 ± 144	612 ± 155	867 ± 133	747 ± 143	909 ± 149	700 ± 161
DI	1846 ± 321	2206 ± 345	1893 ± 326	2151 ± 351	2174 ± 312	1831 ± 338

ANCOVA analysis after log transformation. versus controls. versus controls.